Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Mattel Second Quarter 2025 Earnings Call - 200bp Margin Gain, Tariff Hit Now Under $100M, Guidance Reinstated
Mattel reported a mixed quarter: top line pressure in the U.S. from trade-related retailer ordering shifts and a move from direct import to domestic shipping, but operational moves paid off. Net sales...
- Net sales declined 6% year over year, to $1.02 billion, both as reported and in constant currency.
- Adjusted gross margin expanded 200 basis points to 51.2% in Q2, driven by supply chain efficiencies, mix, and cost savings from the Optimizing for Profitable Growth program.
- Adjusted EPS was unchanged at $0.19 despite revenue weakness, reflecting margin gains and cost discipline.
- +15 more takeaways
QuantumScape Q2 2025 Earnings Call - PowerCo expansion adds up to $131M, pushes commercialization and extends cash runway into 2029
QuantumScape said Q2 marks a commercialization inflection. The company upgraded its PowerCo collaboration, securing up to $131 million in milestone-linked payments over two years to accelerate QSE-5 s...
- QuantumScape expanded its collaboration with PowerCo, adding up to $131 million in milestone-linked payments over the next two years to support joint commercialization and scale-up activities.
- The first milestones tied to more than $10 million have been achieved and QuantumScape expects to invoice PowerCo in Q3 for that amount; preliminary accounting indicates this may not be recognized as revenue.
- PowerCo’s upgraded rights allow production of up to an additional 5 GWh of QS cells annually, bringing its total potential to up to 85 GWh, and include future rights to license advanced QS technology beyond QSE-5.
- +11 more takeaways
Goosehead Insurance Q2 2025 Earnings Call - AI-Driven Service Savings and New Partnerships Power Growth, Even as Premium Mix Lags
Goosehead posted a clean quarter of growth and profitability, with revenue up 20% to $94 million and adjusted EBITDA up 18% to $29.2 million, while scaling its agent base and enterprise pipeline. Mana...
- Revenue rose 20% year over year to $94.0 million, core revenue was $86.8 million, and adjusted EBITDA grew 18% to $29.2 million, implying a 31% adjusted EBITDA margin for the quarter.
- Total written premium was $1.2 billion, up 18% year over year; franchise premiums were $959 million, up 21%, while corporate premiums were $217 million, up 6%.
- Policies in force reached 1.8 million, a 13% increase year over year, and producers per franchise rose to 1.9, up 14% year over year.
- +12 more takeaways
Knight-Swift Transportation Holdings Inc. Q2 2025 Earnings Call - Cost cuts and scale protect margins amid weak freight, LTL expansion pressures profits
Knight-Swift navigated a soft, volatile freight quarter by leaning into cost reduction and scale. Consolidated revenue ex fuel edged up 1.9% while adjusted operating income rose 17.2% year over year, ...
- Consolidated revenue excluding fuel surcharge rose 1.9% year over year in Q2 2025.
- Adjusted operating income grew 17.2% year over year, an improvement of $15.2 million.
- GAAP diluted EPS was $0.21, up 61.5% year over year, adjusted EPS was $0.35, up 45.8% year over year.
- +17 more takeaways
Taylor Morrison Q2 2025 Earnings Call - Spec Inventory Surge Forces Margin-for-Pace Trade-Off
Taylor Morrison reported a steady quarter but with a clear tactical pivot, selling through a record share of spec homes to meet a more cautious, deal-seeking buyer. Q2 closings of 3,340 homes at a $58...
- Q2 closings were 3,340 homes, average closing price $589,000, producing about $2.0 billion of home closings revenue.
- Adjusted home closings gross margin was 23% in Q2, and management said margin has been range bound between 23% and nearly 25% over the last 2.5 years.
- Spec sales surged, management cited a record spec share near 71% of sales in the quarter; CFO cited spec closings penetration of 65% and that 28% of spec inventory sold and closed in the quarter.
- +14 more takeaways
Viking Therapeutics Q2 2025 Earnings Call - Vanquish Phase 3 Initiated, Oral Phase 2 Readout Due H2 and $808M Cash Runway
Viking used this quarter to move from promise to scale. Management kicked off the Vanquish Phase 3 registration program for VK2735 subcutaneous in obesity, completed enrollment in the 13-week Venture ...
- Vanquish Phase 3 launched for VK2735 subcutaneous in obesity, with two 78-week randomized, double-blind, placebo-controlled trials: Vanquish1 ~4,500 adults with obesity or overweight plus comorbidity, Vanquish2 ~1,100 adults with T2D.
- Vanquish dosing arms are 7.5 mg, 12.5 mg, 17.5 mg weekly, primary endpoint percent change in body weight at 78 weeks, plus secondary endpoints for 5/10/15/20% weight loss and open-label extensions.
- Venture Oral Dosing Phase 2 completed enrollment (~280 subjects, six dosing arms plus placebo), top-line results expected in H2 2025; cohorts include high doses up to 120 mg and a maintenance cohort that titrates 90 mg then drops to 30 mg.
- +11 more takeaways
Popular, Inc. Q2 2025 Earnings Call - Loans Jump, ROTCE Hits 13.3% as Buybacks and Dividend Rise
Popular reported a clean second quarter: net income of $210 million, EPS of $3.09, and a 13.3% return on tangible common equity driven by strong loan growth, NII expansion, and improving credit. Manag...
- Q2 net income $210 million, EPS $3.09, up $32 million and $0.53 sequentially, producing a 13.3% ROTCE for the quarter.
- Management announced a $500 million incremental common share repurchase program and raised the quarterly dividend 7% to $0.75 per share, signaling confidence in capital strength.
- Loans increased about $931 million in the quarter; Banco Popular de Puerto Rico contributed ~$681 million and Popular Bank ~$251 million, with commercial and construction lending leading the gains.
- +15 more takeaways
Interpublic Group (IPG) Q2 2025 Earnings Call - Transformation-driven margin surge offsets revenue headwinds
IPG reported a mixed quarter, revenue under pressure but profitability materially stronger. Net revenue fell 6.6% year over year, with organic net revenue down 3.5% and trailing 2024 account losses we...
- Net revenue was $2.2 billion in Q2, down 6.6% year over year, with organic net revenue falling 3.5% as expected.
- Three large account losses in 2024 depressed Q2 growth by about 5.5 percentage points, hitting media and healthcare the hardest.
- Adjusted EBITDA was $393.7 million, delivering an 18.1% margin, the highest Q2 margin on record for IPG.
- +15 more takeaways
BankUnited Inc. Q2 2025 Earnings Call - Deposit Remix and Pricing Discipline Drive Margin Expansion Despite Office NPLs
BankUnited delivered a tidy beat in Q2: net income $68.8 million, $0.91 per share versus consensus near $0.79, with ROA rising to 78 bps and ROE to 9.4%. The quarter was powered by funding remix and p...
- Net income $68.8 million, $0.91 per share, beat consensus (~$0.79); ROA 78 bps, ROE 9.4% for Q2 2025.
- NIDDA and deposits led the quarter: non-broker deposits +$1.2 billion, NIDDA up >$1 billion, average NIDDA +$581 million, now 32% of total deposits.
- Margin and NII improvement driven by mix and pricing discipline: NIM +12 bps to 2.93%, NII +5.6% QoQ.
- +11 more takeaways
Renasant Corporation Second Quarter 2025 Earnings Call - Merger boosts core NIM and balance-sheet growth, reported EPS clouded by purchase accounting and conversion costs
Renasant closed the The First Bancshares deal April 1 and Q2 is the first full quarter of the combined entity. On a reported basis EPS was effectively zero, $0.01, but adjusted earnings were roughly $...
- This is the first full quarter post-close of The First Bancshares, closed April 1, and results reflect the combined company.
- Reported EPS was $0.01, adjusted EPS about $0.69, or roughly $66 million; purchase accounting and one-time items drive the gap.
- Loans increased $312 million, deposits increased $361 million, both roughly 7% versus the combined March 31 balances.
- +14 more takeaways